Capital International Investors Ascendis Pharma A/S Transaction History
Capital International Investors
- $504 Billion
- Q3 2024
A detailed history of Capital International Investors transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Capital International Investors holds 2,109,390 shares of ASND stock, worth $276 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,109,390
Previous 2,104,298
0.24%
Holding current value
$276 Million
Previous $287 Million
9.77%
% of portfolio
0.06%
Previous 0.06%
Shares
11 transactions
Others Institutions Holding ASND
# of Institutions
244Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.27 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$672 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$653 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$577 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$548 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.3B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...